首页> 美国卫生研究院文献>Pharmaceutics >Strong and Selective Inhibitory Effects of the Biflavonoid Selamariscina A against CYP2C8 and CYP2C9 Enzyme Activities in Human Liver Microsomes
【2h】

Strong and Selective Inhibitory Effects of the Biflavonoid Selamariscina A against CYP2C8 and CYP2C9 Enzyme Activities in Human Liver Microsomes

机译:双黄酮Selamariscina A对人肝微粒体中CYP2C8和CYP2C9酶活性的强烈和选择性抑制作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Like flavonoids, biflavonoids, dimeric flavonoids, and polyphenolic plant secondary metabolites have antioxidant, antibacterial, antiviral, anti-inflammatory, and anti-cancer properties. However, there is limited data on their effects on cytochrome P450 (P450) and uridine 5′-diphosphoglucuronosyl transferase (UGT) enzyme activities. In this study we evaluate the inhibitory potential of five biflavonoids against nine P450 activities (P450s1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A) in human liver microsomes (HLMs) using cocktail incubation and liquid chromatography-tandem mass spectrometry (LC–MS/MS). The most strongly inhibited P450 activity was CYP2C8-mediated amodiaquine -dealkylation with IC50 ranges of 0.019~0.123 μM. In addition, the biflavonoids—selamariscina A, amentoflavone, robustaflavone, cupressuflavone, and taiwaniaflavone—noncompetitively inhibited CYP2C8 activity with respective values of 0.018, 0.083, 0.084, 0.103, and 0.142 μM. As selamariscina A showed the strongest effects, we then evaluated it against six UGT isoforms, where it showed weaker inhibition (UGTs1A1, 1A3, 1A4, 1A6, 1A9, and 2B7, IC50 > 1.7 μM). Returning to the P450 activities, selamariscina A inhibited CYP2C9-mediated diclofenac hydroxylation and tolbutamide hydroxylation with respective values of 0.032 and 0.065 μM in a competitive and noncompetitive manner. However, it only weakly inhibited CYP1A2, CYP2B6, and CYP3A with respective values of 3.1, 7.9, and 4.5 μM. We conclude that selamariscina A has selective and strong inhibitory effects on the CYP2C8 and CYP2C9 isoforms. This information might be useful in predicting herb-drug interaction potential between biflavonoids and co-administered drugs mainly metabolized by CYP2C8 and CYP2C9. In addition, selamariscina A might be used as a strong CYP2C8 and CYP2C9 inhibitor in P450 reaction-phenotyping studies to identify drug-metabolizing enzymes responsible for the metabolism of new chemicals.
机译:像类黄酮,双类黄酮,二聚体类黄酮和多酚植物次生代谢产物具有抗氧化,抗菌,抗病毒,抗炎和抗癌的特性。但是,关于它们对细胞色素P450(P450)和尿苷5'-二磷酸葡萄糖醛糖苷转移酶(UGT)酶活性的影响的数据有限。在这项研究中,我们使用鸡尾酒培养和液相色谱串联法评估了五种黄酮类化合物对人肝微粒体(HLM)中九种P450活性(P450s1A2、2A6、2B6、2C8、2C9、2C19、2D6、2E1和3A)的抑制潜力。质谱(LC-MS / MS)。抑制最强的P450活性是CYP2C8介导的氨二喹-脱烷基化作用,IC50范围为0.019〜0.123μM。此外,双黄酮类化合物— —剑兰A,氢黄酮,鲁棒黄酮,铜黄酮和台湾黄酮—非竞争性地抑制CYP2C8活性,其值分别为0.018、0.083、0.084、0.103和0.142μM。由于selamariscina A表现出最强的作用,因此我们针对六种UGT亚型对其进行了评估,其中它们表现出较弱的抑制作用(UGTs1A1、1A3、1A4、1A6、1A9和2B7,IC50> 1.7μM)。返回到P450活性,卷柏A以竞争性和非竞争性的方式抑制CYP2C9介导的双氯芬酸羟化和甲苯磺丁酰胺羟化,其各自的值分别为0.032和0.065μM。但是,它仅以3.1、7.9和4.5μM的值分别弱抑制CYP1A2,CYP2B6和CYP3A。我们得出的结论是,selamariscina A对CYP2C8和CYP2C9亚型具有选择性和强抑制作用。该信息可能有助于预测双黄酮类化合物与主要由CYP2C8和CYP2C9代谢的共同给药药物之间的草药-药物相互作用潜力。此外,Selamariscina A在P450反应表型研究中可能被用作强CYP2C8和CYP2C9抑制剂,以鉴定负责新化学物质代谢的药物代谢酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号